INC Research/inVentiv Health Reports Third Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
INC Research Holdings (INCR) PT Lowered to $46 at Baird Following 3Q Miss
November 10, 2017 9:16 AM ESTBaird lowered its price target on INC Research Holdings (NASDAQ: INCR) to $46.00 (from $67.00) while maintaining a Outperform rating following 3Q. Pro forma adjusted revenue of $767M was down 2%/6% QQ/YY and missed estimates by 1%. Pro forma adjusted EBITDA of $139M... More
